Bayforest Capital’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$239K Sell
4,352
-3,456
-44% -$190K 0.1% 342
2025
Q1
$552K Buy
+7,808
New +$552K 0.24% 139